8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents

Home Editorial Board Reviews Contact Us Search

Anaerobic Bacteria
Authors: Maria Hedberg, Ph.D. , Carl Erik Nord, M.D., Ph.D.

Table of Contents
Monograph Tables What's New Reviews History
Collapse All | Expand All

Microbiology
Epidemiology
MICROBIOLOGY
Clinical Manifestations
Laboratory Diagnosis Anaerobic Gram-positive Non-sporeforming Rods and Anaerobic Gram-positive Cocci
Pathogenesis The anaerobic Gram-positive cocci and anaerobic Gram-positive non-sporeforming rods such as Anaerobic+bacteria,
Susceptibility in Vitro and in Bifidobacterium, Eubacterium, Lactobacillus and Propionibacterium species are, for the most part, components of the normal flora
Vivo of the mucosal surfaces and, to a lesser extent, the skin. They are generally considered to be of relatively low virulence and are
Antimicrobial Therapy especially prevalent in infections associated with predisposing or underlying conditions such as previous surgery, malignancy,
Vaccines immunodeficiency, diabetes and presence of foreign bodies. These opportunistic pathogens are seldom recovered as single
Adjunctive Therapy isolates (13). They are often mixed with other anaerobic or aerobic bacteria. The infections in which this group of microorganisms
Prevention most often has been recovered are skin and soft tissue infections, chronic otitis media and sinusitis, aspiration pneumonia, intra-
Conclusions abdominal infections, gynecological infections, and dental infections (13, 43).

Actinomycosis is an uncommon bacterial infection that has a characteristic chronic indolent course. Anaerobic+bacteria species
are relatively often recovered from female genital tract infections, especially in women using intrauterine contraceptive device.
Although most cases of pelvic actinomycosis are associated with long term use of an intra-uterine device, also other foreign bodies
may cause similar pathogenesis. Recently a case was reported where retained intrauterine fetal bone was detected and the agent
of infection was identified as Anaerobic+bacteria israelii (86). Pelvic actinomycosis associated with intrauterine device might mimic
pelvic malignancy and A. israelii may cause localized tumor-like infections. This species has been reported in a case of renal
actinomycosis mimicking renal carcinoma (24). If the diagnosis of actinomycosis can be obtained preoperatively, antibiotic
treatment may lead to complete resolution (24, 34, 60, 86). Anaerobic+bacteria species are also isolated from patients with dental
infections, anaerobic pleuropulmonary infections, from skin and soft-tissue abscesses in intravenous drug abusers (A.
odontolyticus) and nonintravenous drug abusers (Anaerobic+bacteria sp.) (33). A. radicidentis, has been associated with failed
endodontic treatment (44). Infections caused by Anaerobic+bacteria sp. may also involve the eyes. A.
neuii subspecies anitratus has been isolated from chronic endophthalmitis after cataract surgery (68) and A. israelii was identified
from a case of bilateral blepharokeratoconjunctivitis (36). Both cases were successfully cured by antimicrobial therapy. The rare
species A. turicensis and A. radingae have been isolated from two cases of breast abscess. Both infections displayed chronicity
and required recurrent aspirations and drainage in combination with prolonged antimicrobial therapy to cure (2).

Bifidobacteria are seldom encountered in clinical materials. Bifidobacterium dentium seems to be the major Bifidobacterium with
pathogenic potential. It has been isolated from dental caries, feces and vagina from humans and from lower respiratory tract
specimens. It has also been isolated from a case of peritonsillar abscess together with several other anaerobes
(22). Bifodobacterium sp. was among other anaerobic bacteria reported in a recent study on anaerobes in pleural empyema (9). B.
longum and B. breve are occasionally found in clinical materials. Sepsis caused by B. longum after acupuncture therapy (37) and
neonatal meningitis caused by B. breve has been reported (62).

The genus Eubacterium currently comprises a heterogeneous group of bacteria and recent taxonomic studies have led to the
suggestion of new genera to include species originally placed in the genera Eubacterium. Eubacteria are not frequently isolated
from clinical specimens. They have been reported from anaerobic pleuropulmonary infections and intrauterine contraceptive
device-associated infections (9, 33), in mixed cultures from abscesses, wounds and infections at different sites such as head and
neck, thorax, bone, skin, peritoneal fluid (43) and dental infections (25, 48).

The pathogenic potential of lactobacilli is very low and infections caused by these bacteria are rare, in spite of their ubiquitous
presence in the gastrointestinal tract and their widespread consumption in fermented milk. In a study of lactobacilli and bacteremia
by Saxelin et al. (74), lactobacilli were identified in eight patients among 3,317 blood culture isolates. There was no evidence that
any particular species or subspecies of Lactobacillus was the cause of the infections. Lactobacillus sp. are occasionally recovered
from anaerobic pleuropulmonary infections (9, 33). They may also be involved in other human diseases such as dental caries,
rheumatic vascular disease, septicemia and infective endocarditis (48). In infective endocarditis L. rhamnosus and L.
paracasei subsp. paracasei are quite frequently isolated which suggests that they may have a greater pathogenic potential than
other Lactobacillus species, or it is just a reflection of their relative high numbers in the oral cavity (4, 39). L. rhamnosus has also
been isolated from a liver abscess (69).

Propionibacterium species are colonizing the human skin and mouth and are frequently recovered from mixed infections of the skin
and soft tissue, acne vulgaris and infections linked to operative procedures or foreign bodies (13, 48). Propionibacteria are
dominating in conjunctival cultures from children and adults and have been reported from cases of chronic
infectious endophthalmitis following extracapsular cataract extraction (38). Although serious infections due to P. acnes are rarely
reported it is increasingly recognized in severe infections like blood stream infections, prosthetic joint infections, osteomyelitis,
meningitis and endocarditis (23, 49, 66). Propionibacteria has also been isolated from pleural empyema (9).

The Gram-positive anaerobic cocci are a heterogeneous group of bacteria that form a part of the normal human microflora of the
skin, oral cavity, gut and urogenital tract. Taxonomical changes are ongoing in this group of microorganisms and it has been
suggested that the genus Peptostreptococcus should consist ofPeptostreptococcus anaerobius and P. stomatis. The other species

www.antimicrobe.org/b77.asp 1/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
formerly belonging to this genus have been proposed to be reclassified into new genera that will be used in this chapter
(29,76,77,80). Gram-positive anaerobic cocci are isolated from clinical specimens more often than any group of anaerobic bacteria
exceptBacteroides sp. They are seen particularly in dental infections, head and neck infections, and other infections related to the
oropharyngeal flora, as well as in female genital tract infections where they are the most common anaerobic isolates. They also
seem to have a potential role in mediating impaired wound healing (85). The most frequent species of gram-positive anaerobic
cocci isolated from clinical specimens are Finegoldia magna, Parvimonas micra and Peptinophilus harei (12) and F. magnais
considered as the most pathogen species (76). Gram-positive anaerobic cocci are also one of the major groups isolated from
patients with pulmonary (P. micra, F. magna and Peptostreptococcus anaerobius) (9) and intra-abdominal infections (P. micra). It
has been demonstrated that the predominant anaerobic microorganisms isolated from diabetic foot infections are F. magna,
Peptoniphilus asaccharolyticus, P. anaerobius, and Anaerococcus prevotii (20, 31, 33). The three species of gram-positive
anaerobic cocci most commonly seen in clinical specimens from the intestinal and genital tracts are F. magna, P. anaerobius and P.
asaccharolyticus. A. prevotii and A. tetradius are also clinically important Gram-positive anaerobic cocci. P. micra is frequently
found in periodontal and peritonsillar infections (56, 57, 82) and F. magna has been identified as the cause of infection in five cases
of endocarditis (6). P. asaccharolyticus has been isolated from a renal abscess in a pediatric patient (18). Renal abscess is
uncommon in pediatrics and is rarely a cause of fever of unknown origin, as it was in this special case.

Anaerobic Gram-negative Rods Excluding Bacteroides sp.

Gram-negative anaerobic bacilli are the anaerobes most commonly encountered in clinical infections. Pigmented and non-
pigmented Prevotella species are, after the B. fragilis group and Gram-positive anaerobic cocci, one of the most commonly
encountered group of anaerobic bacteria in human infections.

The pigmented anaerobic Gram-negative rods are composed of species of the genera Prevotella, Porphyromonas and Alistipes
finegoldii (19). Several species of these genera are found in human clinical material and eight of them originate mostly from the
oral cavity (Prevotella corporis, Pr. denticola, Pr. intermedia, Pr. loeschii, Pr. melaninogenica, Pr. nigrescens, Porphyromonas
endodontalis and Po. gingivalis) while Po. asaccharolytica and Po. levii-like organisms are prevalent in the urogenital and intestinal
tracts (43). A. finegoldii has been isolated from appendicitis specimens (19).

Some of the pigmented Porphyromonas and Prevotella species are important pathogens in dental and bite wound infections (43).
They are also isolated from infections of the head, neck, lower respiratory tract and gynecological infections. Pr. corporis, Pr.
intermedia and Po. asaccharolytica have been reported in peritonsillar abscesses, suggesting that these species may have a role
in the pathogenesis of this type of infection. Eighty-four percent of the positive cultures in peritonsillar abscesses have been
reported to contain anaerobic bacteria (57) and similar results were described in a study of pleural empyema where anaerobes
were isolated from 74 % of the cases (9). Periodontal diseases are often associated with a subgingival microflora comprising of
specific potentially pathogenic microorganisms. Among the most important periodontal pathogens associated with adult
periodontitis are considered to be the black pigmented Po. gingivalis and Pr. intermedia (54, 59, 82). Prevotella spp are common
isolates in endodontic infections. Pr. bivia and Pr. disiens are non-pigmented and often isolated from female genital tract infections
and less frequently in oral and respiratory tract infections. The non-pigmented species Pr. oris and Pr. buccae are found in different
oral, pleuropulmonary and other infections (19, 43).

The fusobacteria are normally found in the oropharyngeal and the intestinal tracts. They are often isolated from severe infections
such as peritonsillar abscesses, head and neck infections, brain abscesses, meningitis, gynecological infections and intra-
abdominal abscesses. F. nucleatum is the Fusobacterium species most commonly encountered in clinical infections. F.
necrophorum, F. varium and F. mortiferum are also common clinical isolates (43, 72). F. necrophorum is a very virulent species
causing infections, most often in children or young adults, often originating from pharyngotonsillitis and it has also been
encountered in peritonsillar abscesses in pure cultures (57, 71). It was stated by Bartlett and Gorbach (5) that “F. necrophorum is
another normal cohabitant of the upper airways”, but this has been questioned since no convincing culture evidence exists to
confirm this statement (71). Lemierre’s syndrome is a severe, septicemic illness most commonly caused by F. necrophorum and it
is characterized by an acute oropharyngeal infection, with secondary septic thrombophlebitis of the internal jugular vein and
frequent metastatic infections (11, 71). The microorganism is encountered frequently in mixed infections and, therefore, synergism
between F. necrophorum and other pathogens may play an important role in infections. An association of fusobacterial infections
and infectious mononucleosis has been observed, but more investigations are needed to clarify the correlation between Epstein-
Barr virus and fusobacteria (16, 11). A case of orbital cellulitis caused by F. necrophorum in a previously healthy young female was
reported by Escardo et al. (28). The patient required three sinus debridement operations and 30 days of intravenous antibiotics, but
her vision did not fully recover. Fusobacteria are involved in endodontic infections and are also associated with refractory and
recurrent periodontitis (50, 54, 57, 82). Three chemotherapy-induced neutropenic hematologic patients with severe systemic
infection by F. nucleatum, has been reported (51). The infection was considered to be promoted by a combination of
chemotherapy-induced mucositis, which served as a portal entry for the systemic infection, and the antibiotic regimen (vancomycin)
used in these patients. F. nucleatum has also been isolated from pyarthrosis of the hip, following a transient synovitis in an
otherwise healthy boy (21). Anaerobic bacteria are uncommon pathogens in septic arthritis.

Anaerobic Gram-negative Cocci

Veillonella sp. are small, nonmotile Gram-negative cocci present as commensals in the oropharynx, gastrointestinal tract and
female genital tract. Infections caused by these bacteria are seldom reported, as they in most cases are regarded as normal flora
or non-pathogenic microorganisms. They have been isolated from head and neck infections, skin and soft tissue infections and
infections in the respiratory tract, peritoneal fluid and blood and also bite wound infections (43). The majority of Veillonella sp. from
clinical specimens are V. parvula, but also V. dispar, V. atypica and the newly discovered species V. montpellierensis have been
isolated from human specimens. Veillonella sp. may occur in severe infections such as meningitis and endocarditis (7, 55, 73).

EPIDEMIOLOGY
Anaerobic infections caused by bacteria described in this chapter are mainly endogenic infections, and are therefore not spread
between individuals.

www.antimicrobe.org/b77.asp 2/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
CLINICAL MANIFESTATIONS
The clues listed in Table 1 are not specific except for the odor, but when two or more are present, anaerobic bacteria should be
considered potential pathogens.

LABORATORY DIAGNOSIS
The most important factor in obtaining clinically relevant microbiology culture results is the quality of the specimen. Special
precautions are needed in specimen collection and transport. Contamination by the normal mucosal flora at sampling must be
avoided and the specimen should immediately be placed in a suitable anaerobic transport tube or pouch to avoid exposure to air. A
short transport time to the laboratory is also of great value. The initial processing procedures include direct examination of the
sample (macroscopic: e.g., foul odor, and microscopic: Gram-stain) and inoculation onto appropriate agar media and liquid
anaerobic medium. If possible, specimen processing should be done in an anaerobic chamber to minimize aeration. In the case no
such equipment is available, the sample should be processed within 15 minutes and incubated in an anaerobic environment. The
culture should be incubated at 37oC for at least 48 hours. The Gram-stain is a useful tool since many anaerobes are unique
morphologically. As culture results may not be available for several days this information is very important in deciding the initial
therapy. The microscopic findings must always be correlated to the specimen source. It should also be taken into account that
anaerobic bacteria can act synergistically with non-anaerobic bacteria in the mixed flora of anaerobic infections, or with each other.
Preliminary grouping and even complete identification of some organisms are based on colonial and cellular morphology, Gram
reaction, susceptibility to special potency antibiotic discs, catalase, indole and nitrate reactions. Gas-liquid chromatography is used
to analyze the metabolic end products produced by anaerobic bacteria (43, 64).

Molecular methods (e.g. 16S rRNA PCR-RFLP, sequencing of special regions of 16S rRNA, DNA-DNA hybridization, PFGE) in the
diagnostics of anaerobic bacteria may be useful tools in the everyday clinical microbiological practice as well as in special
situations. Methods for species diagnostics to distinguish species that are otherwise difficult to differentiate, or to identify new
species, detection of slow growing bacteria and non-cultivable microbes, detection of resistance genes and toxins are examples of
areas where molecular methods are successfully used (61, 66). A high proportion of the human microflora cannot be grown in the
laboratory and the cultivable microorganisms are not necessarily the most relevant species.

Despite attractive advantages for species identification, the nucleic acid based methodologies are less useful when polymicrobial
infections are to be analyzed. When PCR-based methods are used, some bacterial species might be discriminated against others
and as a result an incorrect proportion of pathogenic bacteria will be displayed. Such inaccuracy regarding the proportion of
individual pathogens in a polymicrobial infection might hamper the decision of the most adequate therapy (41). In a recent report
on detection of bacteria in placental tissues it was described that, although culture positive samples, no bacteria in the specimens
could be detected by PCR. The negative PCR results were probably due to constituents in the chorionic plate of the placenta that
rapidly degraded or blocked the detection of foreign DNA, thereby preventing identification of the foreign DNA by PCR (65).

PATHOGENESIS
Anaerobic infections may arise in different ways and have a variety of clinical presentations with abscess formation and tissue
necrosis especially common. These infections are derived from the normal flora of the oropharynx, skin, intestinal or female genital
tract. Anaerobic bacteria are generally considered to be of relatively low virulence and are especially prevalent in infections
associated with predisposing or underlying conditions such as trauma or previous surgery, thus affording an opportunity to
penetrate deeper tissues and to set up infection. Other predisposing factors are tissue necrosis, poor blood supply, malignancy,
immunodeficiency, diabetes and presence of foreign bodies. In aspiration pneumonia anaerobic bacteria from a site of normal
carriage (oropharynx) may move into another area normally free of organisms to produce infection at that site. These opportunistic
pathogens are seldom recovered as single isolates. They are often mixed with other anaerobic or aerobic bacteria. The three major
virulence factors in anaerobes are the ability to adhere to or invade epithelial surfaces, the production of toxins or enzymes that
play a pathogenic role, and surface constituents of the organism such as capsular polysaccharide or lipopolysaccharide
(11, 13, 30).

SUSCEPTIBILITY IN VITRO AND IN VIVO

During several years, an increasing resistance to different antimicrobial agents in anaerobic bacteria has been observed.
Anaerobic bacteria are naturally resistant to certain antibiotics, including the aminoglycosides and the earlier quinolones, and many
anaerobes now exhibit resistance to several β-lactam agents as well. Resistance to β-lactam agents is most often caused by
production of β-lactamases, enzymes that inactivate β-lactam compounds by hydrolysis. Changes in the penicillin-binding proteins
(PBP) or blocked penetration of drug into the active site via alteration of the bacterial outer membrane pores are also decreasing
the susceptibility to β-lactam agents. Resistance is more common in Gram-negative than in Gram-positive anaerobic isolates.
Patterns of susceptibility vary in different geographic areas and even in different hospitals in the same city, depending on antibiotic-
prescribing practices. Four groups of drugs are active against almost all anaerobic bacteria of clinical significance: nitroimidazoles,
carbapenems, chloramphenicol, and combinations of β-lactam drugs with a β-lactamase inhibitor (ampicillin/sulbactam,
amoxicillin/clavulanic acid, piperacillin/tazobactam) (Table 2).

The antimicrobial activity of clindamycin is directed against most anaerobic bacteria and clindamycin is therefore often used for
treatment of anaerobic infections. The drug penetrates into bones and joints but does not efficiently cross the blood-brain barrier
and should not be administered in CNS infections (17). It is not active against enterococci and aerobic Gram-negative rods.
Periorally administered clindamycin causes marked ecological disturbances in the normal oropharyngeal and intestinal microflora
and resistant clostridia and enterococci are frequently isolated during and after treatment (53).

Metronidazole is an antimicrobial agent that is often used for treatment and prophylaxis of anaerobic infections. Anaerobic bacteria
sensitive to metronidazole include peptostreptococci, clostridia, bacteroides, fusobacteria, prevotella and porphyromonas. A few
clinical anaerobic isolates, other than B. fragilis, resistant to metronidazole have been reported (58, 67, 82).

Chloramphenicol is a bacteriostatic, highly effective broad-spectrum antimicrobial agent. The drug is very active against many
Gram-positive and Gram-negative bacteria and has an excellent activity against anaerobic bacteria. Chloramphenicol is specially

www.antimicrobe.org/b77.asp 3/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
indicated for use in seriously ill patients when the nature and susceptibility of the infecting bacteria are unknown and in CNS
infections (17). The major side effect is bone marrow toxicity, which complicates the use of chloramphenicol.

Since the bacteria in anaerobic infections are often mixed with aerobic microorganisms, combinations of two antimicrobial agents
may be used in the treatment of these infections, where the microbiological analyses reveal two or more pathogenic species with
different susceptibility patterns. In certain situations, the pharmacologic properties of the drugs and whether or not they are
bactericidal are important considerations. In central nervous system infections, a drug that crosses the blood-brain barrier well
must be used. In such infections and in endocarditis, the bactericidal activity is important (17, 32). Most of the drugs that are active
against anaerobes have good bactericidal activity, except chloramphenicol. Prescription of antimicrobial agents must always be
based on distinct clinical and microbiological diagnoses and the clinical benefits must always be expected to outweigh the
potentially ecological disadvantages and other side effects of the treatment.

Most Gram-positive anaerobic cocci (>90%) isolates are susceptible to β-lactam agents, although cephalosporins may be less
effective (10, 12, 76). In a study by Duerden (26), all except two of 25 Gram positive anaerobic cocci isolates were susceptible to
penicillin. The two resistant strains had MIC values >16 mg/L and neither strain were susceptible to amoxicillin/clavulanate.
Aldridge et al. have also reported similar results in a multicenter surveillance study from the US, where 49 isolates of Gram-positive
anaerobic cocci were examined (1). β-Lactam resistance in Gram-positive cocci seems not to be due to β-lactamase production,
but rather to modifications in the PBPs that frequently involve cross-resistance to cefoxitin and β-lactamase inhibitor combinations.
Macrolide-lincosamide resistance has been shown to be inducible in Gram-positive anaerobic cocci strains and highly resistant
populations in Po. asaccharolytica (MIC>8 mg/L) to erythromycin (30 % resistant strains) and clindamycin (22 % resistant strains)
have also been documented (70). Recent multicenter studies have reported resistance to clindamycin in Gram-positive anaerobic
cocci Prevotella, Porphyromonas and Fusobacterium sp. varying between 4 and 33 % (1, 10, 12, 20, 35, 67).

The information on antimicrobial susceptibility of anaerobic non-sporeforming Gram-positive rods is limited compared with the
information available on the other anaerobic bacterial groups. In general, members of this bacterial group are susceptible to
benzylpenicillin, carbenicillin and chloramphenicol. With few exceptions clindamycin, erythromycin and tetracycline are active
against 60-94 % of isolates tested in this group of bacteria and the rods are commonly resistant to nitroimidazoles (20, 66, 87). In a
recent European surveillance study on antibiotic susceptibility of P. acnes, resistance to clindamycin varied between 0 and 67%
depending on region of isolation (66).

Resistance is increasingly common among anaerobic Gram-negative rods. Approximately two-thirds of Prevotella species are β-
lactamase producers (8, 40, 67,84, 87) and β-lactamase production among oral pigmented Prevotella species is also frequently
present in young children. β-Lactamase production has been studied among different ribotypes of Pr. melaninogenica isolated from
the oral cavity of young children and their mothers. Seventy-six percent of the strains isolated from the children and 69% of the
strains isolated from their mothers were β-lactamase producers (46). Most strains are still susceptible to clindamycin and
metronidazole, while resistant strains to tetracycline have been reported. In a recent study on antimicrobial resistance in anaerobic
bacteria isolated from periodontal infections three of 39Prevotella sp. strains were reported resistant to moxifloxacin (MIC >32
mg/L) (59).

The fusobacteria have become more resistant to antimicrobial agents during the last years. Penicillin-resistant strains due to β-
lactamase production have been found and also clindamycin-resistant strains. The fusobacterial isolates are still susceptible to β-
lactam agents combined with β-lactamase inhibitors. Metronidazole is also active against most strains (1, 33, 9, 82, 87). Most
anaerobic Gram-negative rods are susceptible to metronidazole but there are exceptions: It has been demonstrated in a
Colombian population that metronidazole lacked activity against Fusobacterium strains (45% resistant strains), Prevotella strains
and Porphyromonasstrains (25% resistant strains) isolated from patients with periodontitis (56). The clinical implication of these
findings is unknown.

ANTIMICROBIAL THERAPY

Drugs of Choice
The anaerobic Gram-positive non-sporeforming rods are susceptible to β-lactam agents including penicillins, cephalosporins,
carbapenems and β-lactam/β-lactamase inhibitor combinations which are used for the treatment of infections caused by these
microorganisms. Clindamycin can be given to patients allergic to β-lactam agents while metronidazole is inactive against the
majority of isolates. All strains are susceptible to chloramphenicol.

Most Gram-positive anaerobic cocci are normally susceptible to penicillins and β-lactam/β-lactamase inhibitor combinations.
Clindamycin and metronidazole are less active against Gram-positive anaerobic cocci but can be used in most infections (17).
Gram-positive anaerobic cocci resistant to metronidazole might be microaerophilic species. In two recent surveillance studies on
antimicrobial susceptibility of Gram-positive anaerobic cocci, 4-7 % of the isolates were reported resistant to penicillin and 4-7 % to
clindamycin. No metronidazole resistance was described in these extensive surveys (10, 12). In another recent report by Boyanova
et al. resistance to penicillin and clindamycin in Gram-positive anaerobic cocci was accounted to 21 and 15 % respectively and
metronidazole resistance was found in 16 % of the tested strains (9).

About 70 % of Prevotella strains and 20% of Porphyromonas strains produce β-lactamases making penicillin inactive. The
combination of a β-lactam agent together with a β-lactamase inhibitor is active against these strains (1, 33, 84). In an antimicrobial
susceptibility study by King et al., 68% of the P. bivia strains tested were reported resistant to penicillin. Among the isolates of P.
melaninogenica 60% were resistant, P. denticola 41% and P. oralis 53% (45).

Fusobacterium strains have also been reported to produce β-lactamases. Resistance to β-lactam agents is relatively frequent
among fusobacteria, about 13-30% in Europe and 10-40% in the US (1, 8, 35, 47). β-Lactam-resistant strains of F. nucleatum are
most often seen, but resistant F. varium and F. mortiferum strains have also been isolated. Some strains of these species
produce β-lactamases. β-Lactamase producing F. nucleatum strains has been isolated from the tonsils during penicillintreatment
(81). In a study by Könönen et al., 10 of 20 children ranging in age from 2 to 3.4 years harbored β-lactamase producing F.
nucleatum isolates. They had not received antimicrobial treatment within the last month preceding the specimen collection (47).

www.antimicrobe.org/b77.asp 4/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
As Fusobacterium species are intrinsically resistant to erythromycin, which is often the alternative antibiotic for the treatment of
upper respiratory tract infections in patients allergic to penicillin, a combination of erythromycin or penicillin with metronidazole will
provide protection against both the aerobic and anaerobic pathogens. Alternatively clindamycin, chloramphenicol, imipenem or a β-
lactam agent in combination with a β-lactamase inhibitor can be effective (11).

Special Infection
Anaerobic Endocarditis
Anaerobic endocarditis is a rare but serious infection with a mortality rate of 21-43 % and it accounts for 2-16 % of all cases of
infective endocarditis (15). Gram-positive anaerobic cocci and Bacteroides fragilis are most often causing anaerobic endocarditis.
In patients with prosthetic heart valves, vascular grafts or intravascular prosthesis, endovascular infections caused by lactobacilli,
propionibacteria and bifidobacteria have been reported. Benzylpenicillin is considered to be the agent of choice for treatment of
endocarditis caused by Gram-positive anaerobic cocci, lactobacilli, propionibacteria and bifidobacteria (33). In a report of
endocarditis caused by F. magna it was concluded that the diagnosis seems to be depending on the blood culture system used, as
some of these patients had several negative blood cultures before the infecting microorganism finally was detected (6). The
incidence of infective endocarditis caused by Propionibacterium sp. is low, a fact that limits the understanding of the disease. The
diagnosis of Propionibacteriumendocarditis is often missed or delayed due to the prolonged incubation (7-14 days) required for
isolation of these bacteria from blood cultures, as well as the difficulty to differentiate whether the positive cultures represent skin
contamination or a true bacteremia. A large multinational study of Propionibacterium infective endocarditis was recently conducted
to examine clinical features, complications and outcomes of 15 cases, using prospectively collected data. Prosthetic valve
endocarditis occurred in 13 of 15 patients and clinical findings included valvular vegetation in nine cases and cardiac abscesses in
three cases. Ten of 15 patients underwent valve replacement surgery and two died (49). The infections indolent clinical course and
negative blood cultures may delay appropriate therapy and contribute to abscess formation. P. acnes is the most frequently
reported species in Propionibacterium endocarditis and the most common antimicrobial therapy is penicillin alone or in combination
with an aminoglycoside (23).

Anaerobic Pericarditis
Anaerobic bacteria have only rarely been isolated from pericardial fluid. In a review by Skiest et al. 30 cases of pericarditis were
reported, in which at least one specific type of anaerobic bacteria was implicated (75). The anaerobes were isolated from the
pericardial fluid in 27 cases and from the blood in three cases. In these three cases the cultures of purulent pericardial fluid were
sterile. The following anaerobic organisms were isolated: Bacteroides species (includingPrevotella species), "anaerobic
streptococci", peptostreptococci, Clostridium species, Fusobacterium species and Bifidobacterium species. The mortality rate was
52%. No firm conclusion concerning the impact of treatment on outcome could be drawn because of the small number of cases.
Cases due to Anaerobic+bacteria were excluded from the review. For patients with odontogenic infections, esophageal diseases,
anaerobic pleuropulmonary infections, intraabdominal infections, or pelvic infections, purulent pericarditis may be caused by
anaerobic bacteria. In all cases of pericarditis there should be a search for the source of the organism infecting the pericardium and
initial antimicrobial therapy should include antibiotics directed against anaerobic bacteria (75).

Anaerobic Meningitis
Anaerobic bacteria are uncommon as the etiology of meningitis. Anaerobic bacterial meningitis occurs in older children and adults
with chronic sinusitis, chronic otitis media or bowel diseases. Benzylpenicillin is recommended for treatment of meningitis due to
Gram-positive anaerobic cocci and propionibacteria (33). Chloramphenicol has also been used. Recently meropenem has shown
to be useful for treatment of pneumococcal meningitis. It may therefore also be used for Gram-positive anaerobic cocci meningitis
(63). Meningitis caused by F. necrophorum has high mortality (33 %) and morbidity (60 %). Two cases of fatal meningitis in children
(4 and 5 years old) due to F. necrophorum were recently reported by Veldhoen et al. The children were previously healthy and a
few weeks before admission they were both diagnosed with otitis media for which they were treated with antimicrobials, one of
them with amoxicillin and the other with neomycin. At admission they were acutely ill with symptoms like high-grade fever,
headache and vomiting. In the first case computed tomography scan (CT-scan) revealed no abnormalities at admission, but
cerebrospinal fluid examination indicated leukocytosis and ceftriaxone was immediately initiated. A new CT-scan 12 hours later
showed mastoiditis and suggestive pus in the ventricular system. Gram-negative rods identified as F. necrophorum was grown from
blood and cerebrospinal fluid within 12 hours and the antibiotic was changed to meropenem. The F. necrophrum infection was
rapidly progressing and a CT-scan made 12 hours after the second one revealed multiple hypodense areas, probably ischemic
zones, and eight hours later the child was declared clinically brain dead. In the second case initial findings by CT-scan indicated
mastoiditis and Pseudomonas was at first suspected as the infecting agent. The patient’s neurologic condition deteriorated rapidly
during the next six hours despite meropenem therapy. A new CT-scan displayed among other findings, multiple cerebral infarcts
and jugular vein thrombosis. A few days later the child was declared brain dead and F. necrophorum was grown from blood and
cerebrospinal fluid. Microbiological diagnosis can be easily missed or delayed as F. necrophorum can only be isolated under strict
anaerobic conditions and may require prolonged incubation (83). Meningitis caused by V. parvula was recently reported by Bhatti
and Frank. A predisposing factor in this case was probably a chronic sinusitis. The V. parvula isolate was grown from spinal fluid,
while blood cultures from the day of admission yielded P. intermedia and P. anaerobius and a culture of fluid from the right
sphenoid grew Enterobacter cloacae and P. acnes. The patient was cured after a 6-week course of ceftriaxone and metronidazole
(7).

Anaerobic Liver Abscess

From liver abscesses the following anaerobic bacteria are most often isolated: Gram-positive anaerobic cocci, bacteroides and
fusobacteria. The most common sources are biliary tract and other intraabdominal infections. A few cases of liver abscesses due
to Lactobacillus spp. have been reported. In one case L. rhamnosus was isolated from a 74-year woman with a several year history
of hypertension and non-insulin-dependant diabetes mellitus. The bacterium was indistinguishable from L. rhamnosus strain GG,
which is used in diary products in Finland. Four months before her symptom onset, she had a daily intake of one-half litre dairy
drinks containing L. rhamnosus strain GG, to relieve abdominal discomfort (69). Successful treatment of liver abscess requires
drainage of the abscess and appropriate antimicrobial therapy. If the underlying source of infection such as bowel perforation or
bile duct obstruction must be controlled, surgical drainage is indicated. Empiric antimicrobial treatment is recommended to start
before the surgical drainage. A combination with an aminoglycoside plus metronidazoleor clindamycin will give an optimal
coverage for the aerobic and anaerobic bacteria involved. Carbapenems like imipenem and meropenem have also been used
successfully for treatment of these infections (63).

www.antimicrobe.org/b77.asp 5/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
Anaerobic Discitis
Staphylococcus aureus or other aerobic and facultative microorganisms generally cause diskitis, an inflammation of the invertebral
disk. Anaerobic bacteria have been isolated from adults with spondylodiscitis, but this has not been reported in children. The
recovery of anaerobic bacteria in two children with diskitis was recently published. One patient was a 10-year old boy. The blood
culture showed no growth, but a Gram stain from the infected site revealed Gram-positive cocci in chains. Anaerobic cultures
yielded heavy growth of F. magna, which was susceptible to penicillin, clindamycin and vancomycin (14). The other patient was an
8-year old boy. One month earlier he had an upper respiratory tract infection with sore throat, for which he had no therapy.
Aspirated material from the disc space was sent for aerobic and anaerobic cultures. Gram stain showed fusiform Gram-negative
bacilli and the anaerobic culture showed light growth of F. nucleatum. The strain produced β-lactamase and was susceptible
to ticarcillin-clavulanate, clindamycin, metronidazole and imipenem (14). Veillonella sp. has also been identified as a cause of
anaerobic diskitis. A 27-year-old man was admitted to the hospital after a 3-week history of low back pain. The onset of pain was
abrupt with no identifiable precipitating factor. Spinal motion was limited in all planes and a CT-scan revealed a disk herniation. The
pain persisted and at the 33rd hospital day laboratory tests disclosed worsening inflammation and findings from magnetic
resonance imaging of the lumbar spine suggested diskitis. Culture from a fine needle biopsy of the disk grew Veillonella sp. No
portal of entry could be located, the patient was treated with amoxicillin for 11 weeks and was finally cured (42). A similar situation
withveillonella-diskitis was reported by Marriott et al., although in this case the predisposing factor probably was a routine
endoscopy that the patient underwent two months earlier. The initial antimicrobial treatment for the infection was flucloxacillin and
ceftriaxone, but despite the therapy fever and pain worsened. Six days after admission V. parvula was isolated from disk aspirate
and blood. The antibiotic was changed to cefotaxime and later on to amoxicillin-clavulanic acid that completed a total of 3 months
successful antimicrobial therapy (55). In many cases no bacterial growth is obtained from infected invertebral discs, which might be
caused by improper methods for their collection, transport and cultivation. Proper choice of antimicrobial therapy of diskitis can be
accomplished only by identification of the causative organisms and its antimicrobial susceptibility. This is particular important in
infections caused by anaerobic bacteria that are often resistant to antimicrobial agents used to empirically treat diskitis (14).

Underlying Diseases
Anaerobic infections are often associated with predisposing or underlying conditions where host defenses are impaired, such as
previous surgery, impaired blood supply, malignancy, immunodeficiency, diabetes and presence of foreign bodies. Tissue necrosis
or poor blood supply lowers the oxidation-reduction potential, favoring the growth of anaerobic organisms. To cure the infection
underlying factors should be traced and eliminated if possible. In a study by Lark et al., F. nucleatumand Leptotrichia buccalis were
reported as the most frequently isolated anaerobic bacteria from bloodstream infections in patients who underwent bone marrow
transplantation (52). In elderly and immunocompromised patients Lactobacillus sp. have been identified as potential emerging
pathogens, particularly in those patients receiving broad spectrum antibiotic therapy (3).

Alternative Therapy
Moxifloxacin, a methoxyfluoroquinolone, has a broad spectrum of antibacterial activity and has been shown to be useful in mixed
aerobic and anaerobic infections. The compound has good activity against anaerobes in addition to enhanced activity against
Gram-positive bacteria as compared to earlier quinolones, like ciprofloxacin, ofloxacin and norfloxacin. Moxifloxacin is particularly
active against microorganisms causing respiratory tract infections and skin and soft tissue infections (79). However, resistance to
this agent seems to increase among several genera of anaerobic bacteria such as the B. fragilis group (20, 79, 87).

Linezolid belongs to a class of synthetic antimicrobial agents called oxazolidinones. The agent is active against many clinically
important Gram-positive bacteria including methicillin-resistant staphylococci, vancomycin-resistant enterococci and penicillin-
resistant pneumococci. This compound does generally not inhibit Gram-negative aerobic bacteria. Linezolid has excellent activity
against Gram-positive anaerobic microorganism, and exhibits also activity against Gram-negative anaerobic bacteria (27).
Linezolid may be used for treatment of anaerobic infections. Sporadic isolates of Prevotella sp., anaerobic cocci and anaerobic
Gram-positive rods resistant to linezolid have recently been reported (87).

Tigecycline is the first glycycline antibiotic to be approved by the US Food and Drug Administration. The compound is active
against a wide range of bacteria: e.g. Gram-positive and Gram-negative bacteria, methicillin resistant Staphylococcus aureus,
vancomycin resistant enterococci and extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae as
well as several anaerobic bacteria but lacks activity against Pseudomonas aeruginosa. The drug is unique for its ability to be used
as monotherapy for empirical coverage of various drug resistant pathogens and polymicrobial infections. Because of poor oral
absorption, tigecycline should be given parenterally (78). Resistance to tigecycline among anaerobes has been reported in
the Bacteroides fragilis group (19 %) and a few isolates of clostridia but not in other anaerobes (87).

VACCINES
At present, no vaccines against anaerobic bacteria are available. The anaerobic bacteria consist a great part of the normal
microflora and the immune response is therefore low.

ADJUNCTIVE THERAPY
The two key approaches to treatment of infections involving anaerobic bacteria are surgery and antimicrobial therapy. In most
anaerobic infections (except pulmonary), surgical drainage and debridement are necessary for a favorable outcome. Failure to
carry out essential surgical therapy may lead to poor or no response to appropriate antimicrobial agents. Other modes of therapy
such as hyperbaric oxygen (HBO) and hydrogen peroxide occasionally may be useful in selected circumstances (30, 33).

PREVENTION
Most of the anaerobic bacteria involved in infection are present as normal flora at various sites in the human body, which makes
prevention of anaerobic infections difficult.

CONCLUSIONS

www.antimicrobe.org/b77.asp 6/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
Anaerobic bacteria are important pathogens in many different infections. During the last years, resistance to several antimicrobial
agents in anaerobic bacteria has been more frequently described (1, 10, 12, 20, 35, 45, 59, 66, 67, 87). While other groups of
anaerobic bacteria have remained substantially stable in their susceptibility patterns, the Bacteroides genus and the
genera Prevotella and Porphyromonas have become increasingly resistant to many anti-anaerobic agents such as penicillins and
cephalosporins. Antimicrobial agents commonly used in the treatment of anaerobic infections are ß-lactam antibiotics
(carbapenems), metronidazole and ß-lactam compounds (ampicillin, amoxicillin, ticarcillin and piperacillin) in combination with a ß-
lactamase inhibitor, such as clavulanic acid, sulbactam, or tazobactam. The broad-spectrum quinolones moxifloxacin and
gatifloxacin have potential to treat mixed aerobic and anaerobic infections, however resistance to these agents seems to increase
among several genera of anaerobic bacteria (20, 79, 87). New antimicrobial agents such as linezolid and tigecycline may be an
alternative in the therapy of anaerobic infections. The treatment of anaerobic infections must be individualized, taking into account
the site, type, extent and severity of the infection. Empiric antimicrobial therapy is frequently used in the treatment of anaerobic
infections as it might take several days for bacterial cultures to grow and, in many cases, the patient needs care without delay. The
antibiotic resistance patterns are no longer predictable in anaerobic bacteria and the first choice of antibiotic might not be sufficient.
Antimicrobial susceptibility testing of the infecting microorganisms will give essential information of the alternatives for treatment.
The patient’s condition and the nature of the infecting microorganisms are of extreme importance.

REFERENCES
1. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of the changing in vitro
antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and
Peptostreptococcus species. Antimicrob Agents Chemother 2001;45:1238-1243. [PubMed]

2. Attar KH, Waghorn D, Lyons M, Cunnick G. Rare species of Actinomyces as causative pathogens in breast abscess. Breast J
2007;18:501-505. [PubMed]

3. Antony SJ. Lactobacillemia: an emerging cause of infection in both the immunocompromised and immunocompetent host. J Natl
Med Assoc 2000;92:83-86.[PubMed]

4. Avlami A, Kordossis T, Vrizidis N, Sipsas NV. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 2001;
42:283-285. [PubMed]

5. Bartlett JG, Gorbach SL. Anaerobic infections of the head and neck. Otolaryng Clin N Am 1976;9:655-678. [PubMed]

6. Bassetti S, Laifer G, Goy G, Fluckiger U, Frei R. Endocarditis caused by Finegoldia magna (formerly Peptostreptococcus
magnus): diagnosis depends on the blood culture system used. Diagn Microbiol Infect Dis 2003;47:359-360. [PubMed]

7. Bhatti MA, Frank MO. Veillonella parvula meningitis: Case report and review of Veillonella infections. Clin Infect Dis
2000;31:839-840. [PubMed]

8. Behra-Miellet J, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Fosse T, Goldstein F, Jaulhac B,
Dubreuil L. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicenter survey. Anaerobe
2003;9:105-111. [PubMed]

9. Boyanova L, Djambazov V, Gergova G, Iotov D, Petrov D, Osmanliev D, Minchev Z, Mitov I. Anaerobic microbiology in 198
cases of pleural empyema: a Bulgarian study. Anaerobe 2004;10:261-267. [PubMed]

10. Brazier JS, Hall V, Morris TE, Gal M, Duerden BI. Antibiotic susceptibilities of Gram-positive anaerobic cocci: result of a
sentinel study in England and Wales. J Antimicrob Chemother 2003;52:224-228. [PubMed]

11. Brazier JS. Human infections with Fusobacterium necrophorum. Anaerobe 2006;12:165-172. [PubMed]

12. Brazier J, Chmelar L, Dubreuil L, Feierl G, Hedberg M, Kalenic S, Könönen E, Lundgren B, Malamou-Ladas H, Nagy E,
Sullivan Å, Nord CE. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci. Int J Antimicrob
Agents 2008;31:316-320.

13. Brook I, Frazier EH. Significant recovery of nonsporulating anaerobic rods from clinical specimens. Clin Infect Dis 1993;16:476-
480. [PubMed]

14. Brook I. Two cases of diskitis attributable to anaerobic bacteria in children. Pediatrics 2001;107:E26.[PubMed]

15. Brook I. Endocarditis due to anaerobic bacteria. Cardiology 2002;98:1-5. [PubMed]

16. Brook I. The association of anaerobic bacteria with infectious mononucleosis. Anaerobe 2005;11:308-311. [PubMed]

17. Brook I. Treatment of anaerobic infection. Expert Rev Anti Infect Ther 2007;5:991-1006. [PubMed]

18. Casullo VA, Bottone E, Herold BC. Peptostreptococcus asaccharolyticus renal abscess: a rare cause of fever of unknown
origin. Pediatrics 2001;107(1):E11.[PubMed]

19. Citron DM, Poxton IR, Baron EJ. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic Gram-negative
rods. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology, 9th ed, p. 911-932. ASM
Press, Washington, DC, 2007.

20. Citron DM, Goldstein EJC, Vreni Merriam C, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot
infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007;45:2819-2828. [PubMed]

21. Chryssagi AM, Brusselmans CB, Rombouts JJ. Septic arthritis of the hip due to Fusobacterium nucleatum. Clin Rheumatol
2001;20:229-231. [PubMed]

www.antimicrobe.org/b77.asp 7/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
22. Civen R, Vaisanen ML, Finegold SM. Peritonsillar abscess, retropharyngeal abscess, mediastinitis, and nonclostridial
anaerobic myonecrosis: a case report. 1993; Clin Infect Dis 16(Suppl 4):S299-303. [PubMed]

23. Clayton JJ, Baig W, Reynolds GW, Sandoe JAT. Endocarditis caused by Propionibacterium species: a report of three cases
and a review of clinical features and diagnostic difficulties. J Med Microbiol 2006;55:981-987. [PubMed]

24. Dieckmann KP, Henke RP, Ovenbeck R. Renal actinomycosis mimicking renal carcinoma. Eur Urol 2001;17:134-136. [PubMed]

25. Downes J, Munson MA, Spratt DA, Könönen E, Tarkka E, Jousimies-Somers H, Wade WG. Characterisation of Eubacterium-
like strains isolated from oral infections. J Med Microbiol 2001;50:947-951. [PubMed]

26. Duerden BI. Role of the reference laboratory in susceptible testing of anaerobes and a survey of isolates referred from
laboratories in England and Wales during 1993-1994. Clin Infect Dis 1995;20(Suppl 2):S180-186. [PubMed]

27. Edlund C, Oh H, Nord CE. In vitro activity of linezolid and eperezolid against anaerobic bacteria. Clin Microbiol Infect 1999;5:
51-53. [PubMed]

28. Escardo JA, Feyi-Wabaso A, Lane CM, Morgan JE. Orbital cellulitis caused by Fusobacterium necrophorum. Am J Ophtalmol
2001;131:280-281. [PubMed]

29. Ezaki T, Kawamura Y, Li N, Li ZY, Zhao L, Shu S. Proposal of the genera Anaerococcus gen. nov., Peptoniphilus gen. nov. and
Gallicola gen. nov. for members of the genus Peptostreptococcus. Int J Syst Evol Microbiol 2001;51:1521-1528. [PubMed]

30. Finegold SM, Baron EJ, Wexler HM. A clinical guide to anaerobic infections. Star Publishing Company, 1992.

31. Finegold SM. Overview of clinically important anaerobes. Clin Infect Dis 1995;20(Suppl 2):S205-207. [PubMed]

32. Finegold SM. Anaerobic infections in humans. Anaerobe 1995;1:3-9.

33. Finegold SM, Wexler HM. Present status of therapy for anaerobic infections. Clin Infect Dis 1996;23:S9-S14. [PubMed]

34. Fiorino AS. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear.
Obstetrics and Gynecology 1996;87:142-149. [PubMed]

35. García-Rodríguez JA, García-Sánches JE, Muños-Bellido JL. Antimicrobial resistance in anaerobic bacteria: Current situation.
Anaerobe 1995;1:69-80.

36. Goel R, Malik KP, Gaind R, Goel A. Bilateral actinomycotic blepharokeratoconjuctivits. Orbit 2007;26:53-55. [PubMed]

37. Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. 1999; J Clin Microbiol 37(4):1227-
1228. [PubMed]

38. Hall GS, Pratt-Rippin K, Meisler DM, Washington JA, Roussel TJ, Miller D. Minimum bactericidal concentrations of
Propionebacterium acnes isolates from cases of chronic endophthalmitis. Diagn Microbiol Infect Dis 1995;21:187-190. [PubMed]

39. Harty DWS, Oakey HJ, Patrikakis M, Hume EBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol
1994;24:179-189. [PubMed]

40. Hecht DW. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe 2006;12:115-
121. [PubMed]

41. Horz HP, Conrads G. Diagnosis and anti-infective therapy of periodontitis. Expert Rev Anti Infect Ther 2007;5:703-
715. [PubMed]

42. Isner-Horobeti ME, Lecocq J, Dupeyron A, De Martino SJ, Froehlig P, Vautravers P. Veillonella discitis. A case report. Joint
Bone Spine 2006;113-115. [PubMed]

43. Jousimies-Somer H, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth-KTL anaerobic bacteriology
manual 6th ed. Belmont, CA: Star Publishing Co.; 2002.

44. Kalfas S, Figdor D, Sundqvist G. A new bacterial species associated with failed endodontic treatment: identification and
description of Actinomyces radicidentis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 92:208-214. [PubMed]

45. King A, Downes J, Nord CE, Phillips I. Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative
bacilli in Europe. Clin Microbiol Infect 1999;5:404-416. [PubMed]

46. Könönen E, Saarela M, Kanervo A, Karjalainen J, Asikainen S, Jousimies-Somer H. β-Lactamase production and penicillin
susceptibility among different ribotypes of Prevotella melaninogenica simultaneously colonizing the oral cavity. Clin Infect Dis
1995;20: (Suppl 2):S364-366. [PubMed]

47. Könönen E, Kanervo E, Salminen K, Jousimies-Somer H. Beta-lactamase production and antimicrobial susceptibility of oral
heterogenous Fusobacterium nucleatum populations in young children. Antimicrob Agents Chemother 1999;43:1270-
1273. [PubMed]

48. Könönen E, Wade WG. Propionibacterium, Lactobacillus, Actinomyces, and other non-spore-forming anaerobic Gram-positive
rods. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology, 9th ed, p. 872-888. ASM
Press, Washington, DC, 2007.

www.antimicrobe.org/b77.asp 8/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
49. Lalani T, Person AK, Hedayati SS, Moore L, Murdoch DR, Hoen B, Peterson G, Shahbaz H, Raoult D, Miro JM, Olaison L,
Snygg-Martino U, Suter F, Spelman D, Eykyn S, Strahilevitz J, Van der Meer JT, Verhagen D, Baloch K, Abrutyn E, Cabell CH.
Propionibacterium endocarditis: a case series from the international collaboration on endocarditis merged database and
prospective cohort study. Scand J Infect Dis 2007;39:840-848. [PubMed]

50. Lana MA, Ribeiro-Sobrinho AP, Stehling R, Garcia GD, Silva BK, Hamdan JS, Nicoli JR, Carvalho MA, Farias LD.
Microorganisms isolated from root canals presenting necrotic pulp and their drug susceptibility in vitro. Oral Microbiol Immunol
2001;16:100-105. [PubMed]

51. Landsaat PM, van der Lelie H, Bongaerts G, Kuijper EJ. Fusobacterium nucleatum, a new invasive pathogen in neutropenic
patients? Scand J Infect Dis 1995;27:83-84. [PubMed]

52. Lark RL, McNeil SA, van der Hyde K, Noorani Z, Uberti J, Chenoweth C. Risk factors for anaerobic blood stream infections in
bone marrow transplant recipients. Clin Infect Dis 2001;33:338-343. [PubMed]

53. Lidbeck A, Edlund C, Gustafsson J-Å, Kager L, Nord CE. Impact of Lactobacillus acidophilus on the normal intestinal microflora
after administration of two antimicrobial agents. Infection 1988;16:329-336. [PubMed]

54. Listgarten MA, Lai CH, Young V. Microbial composition and pattern of antibiotic resistance in subgingival microbial samples
from patients with refractory periodontitis. J Periodontol 1993;64:155-161. [PubMed]

55. Marriott D, Stark D, Harkness J. Veillonella parvula discitis and secondary bacteremia: A rare infection complicating endoscopy
and colonoscopy? J Clin Microbiol 2007;45:672-674.[PubMed]

56. Meíja GI, Botero A, Rojas W, Robledo JA. Refractory periodontitis in a Colombian population: Predominant anaerobic bacterial
flora and antibiotic susceptibility. Clin Infect Dis 1995;20 (Suppl 2):S311-313. [PubMed]

57. Mitchlemore IJ, Prior AJ, Montgomery PQ, Tabaqchali S. Microbiological features and pathogenesis of peritonsillar abscesses.
Eur J Clin Microbiol Infect Dis 1995;14:870-877. [PubMed]

58. Mory F, Carlier JP, Alauzet C, Thouvenin M, Schuhmacher H, Lozniewski A. Bacteremia caused by a metronidazole-resistant
Prevotella sp. strain. J Clin Microbiol 2005;43:5380-5383. [PubMed]

59. Mosca A, Miragliotta L, Iodice MA, Abbinante A, Miragliotta G. Antimicrobial profiles of Prevotella spp. and Fusobacterium
nucleatum isolated from periodontal infections in a selected area of southern Italy. Int J Antimicrob Agents 2007;30:521-
524. [PubMed]

60. Muller-Holzner E, Ruth NR, Abfalter E, Schrocksnadel H, Dapunt O, Martin-Sances L, Nogales FF. IUD-associated pelvic
actinomycosis: a report of five cases. Int J Gynecol Pathol 1995;14:70-74. [PubMed]

61. Nagy E, Urbán E, Sóki J, Terhes G, Nagy K. The place of molecular gentic methods in the diagnosis of human pathogenic
anaerobic bacteria. A minireview. Acta Microbiol Immunol Hung 2006;53:183-194. [PubMed]

62. Nakazava T, Kaneko K, Takahashi H, Inoue S. Neonatal meningitis caused by Bifidobacterium breve. Brain and Development
1996;18:160-162. [PubMed]

63. Norrby SR, Newell PA, Faulkner KL, Lesky W. Safety profile of meropenem: international clinical experience based on the first
3125 patients treated with meropenem. J Antimicrob Chemother 1995;36 (Suppl A):S207-223. [PubMed]

64. Olsen I, Solberg CO, Finegold SM. A primer on anaerobic bacteria and anaerobic infections for the uninitiated.
Infection1999;27:159-165. [PubMed]

65. Onderdonk AB, Delaney ML, DuBois AM, Allred EN, Leviton A. Detection of bacteria in placental tissues obtained from
extremely low gestational neonates. Am J Obst Gyn 2008. [PubMed]

66. Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol
Infect Dis 2005;11:204-213. [PubMed]

67. Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, the Hellenic Study Group for Gram-negative bacteria, Avlamis A.
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-
negative anaerobic bacteria in Greece. Clin Microbiol Infect Dis 2005;11:820-824.[PubMed]

68. Pérez-Santonja JJ, Campos-Mollo E, Fuentes-Campos E, Samper-Giménez J, Alió JL. Actinomyces neuii subspecies anitratus
chronic endophtalmitis after cataract surgery. Eur J Ophthalmol 2007;17:445-447. [PubMed]

69. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. Liver abscess due to a
Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28:1159-1160.[PubMed]

70. Reig M, Moreno A, Baquero F. Resistance in Peptostreptococcus spp. to macrolides and lincosamides: Inducible and
constitutive phenotypes. Antimicrob Agents Chemother 1992;36:662-664. [PubMed]

71. Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with focus on Lemierre’s syndrome. Clin
Microbiol Rev 2007;20:622-659.[PubMed]

72. Roberts GL. Fusobacterial infections: an underestimated threat. Br J Biomed Sci 2000;57:156-162. [PubMed]

73. Rovery C, Etienne A, Foucault C, Berger P, Brouqui P. Veillonella montpellierensis endocarditis. Emerg Infect Dis
2005;11:1112-1114. [PubMed]

www.antimicrobe.org/b77.asp 9/10
8/14/2020 Anaerobic Bacteria - Infectious Disease and Antimicrobial Agents
74. Saxelin M, Chuang NH, Chassy B, Rautelin H, Mäkelä PH, Salminen S, Gorbach SL. Lactobacilli and bacteremia in southern
Finland, 1989-1992. Clin Inf Dis 1996;22:564-566. [PubMed]

75. Skiest DJ, Steiner D, Werner M, Garner JG. Anaerobic pericarditis: case report and review. Clin Infect Dis 1994;19:435-
440. [PubMed]

76. Song Y, Finegold SM. Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and other anaerobic cocci. In:
Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology, 9th ed, p. 862-871. ASM Press,
Washington, DC, 2007.

77. Song Y, Lui C, Finegold SM. Development of a flow chart for identification of Gram Positive anaerobic cocci in the clinical
laboratory. J Clin Microbiol 2007;45:512-516. [PubMed]

78. Stein GE, Craig WA. Tigecycline: A critical analysis. Clin Infect Dis 2006;43:518-24. [PubMed]

79. Stein GE, Goldstein EJC. Fluoroquinolones and anaerobes. Clin Infect Dis 2006;42:1598-1607. [PubMed]

80. Tindall BJ, Euzéby JP. Proposal of Parvimonas gen. nov. and Quatrionicoccus gen. nov. as replacements for the illegitimate,
prokaryotic, generic names Micromonas Murdoch and Shah 2000 and Quadricoccus Maszenan et al. 2002, respectively. Int J Syst
Evol Microbiol 2006;56:2711-2713. [PubMed]

81. Tunér K, Lindqvist L, Nord CE. Purification and properties of a novel ß-lactamase from Fusobacterium nucleatum. Antimicrob
Agents Chemother 1985;27:943-947. [PubMed]

82. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis
patients in the Netherlands and Spain. J Clin Periodontol 2005;32:893-898. [PubMed]

83. Veldhoen ES, Wolfs TF, van Vught AJ. Two cases of fatal meningitis due to Fusobacterium necrophorum. Pediatr Neurol
2007;36:261-263. [PubMed]

84. Vreni Merriam C, Citron DM, Tyrrell KL. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral
anaerobes and 31 strains of Eikenella corrodens. Int J Antimicrob Agents 2006;28:244-248. [PubMed]

85. Wall IB, Davies CE, Hill KE, Wilson MJ, Stephens P, Harding KG, Thomas DW. Potential role of anaerobic cocci in impaired
human wound healing. Wound Repair Regen 2002;10:346-353. [PubMed]

86. White T, Felix JC. Pelvic actinomycocis with retained fetal bone: a case report. J Reprod Med 2007;52:220-222.[PubMed]

87. Wybo I, Piérard D, Verschraegen I, Reynders M, Vandoorslaer K, Claeys G, Delmée M, Glupczynski Y, Gordt B, Ieven M, Melin
P, Struelens M, Verhaegen J, Lauwers S. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J
Antimicrob Chemother 2007;59:132-139.[PubMed]

© 2010-2017. E-Sun Technologies, Inc. No portion of this site may be reproduced.

www.antimicrobe.org/b77.asp 10/10